Influenza or flu is a transmittable respiratory disease which affect nose, throat, and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be either seasonal, pandemic, or zoonotic. Influenza can be fatal if goes unnoticed and is regarded as a major reason of mortality, globally. Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache. Children below 2 years of age and elderly above 65 years of age are at high risk of developing chronic flu.
Browse market data tables and in-depth TOC of the Asia-Pacific Influenza Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/
The growth of Influenza market is majorly driven by factors such as rising public awareness, boost in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, in Asia-Pacific are not immunized against influenza virus, thereby fueling the demand for the product in the region. The key restraints of the market are antigenic shift of influenza virus, lack of cold storage facility, side-effects of product (soreness, allergic reactions, swelling, and redness), and remote areas with limited accessibility.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/request-sample

Asia-Pacific Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults.The Asia-Pacific market is geographically segmented into China, India, Japan, South Korea and Australia.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/inquire
The major companies dominating Asia-Pacific Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).
Avail discount @ http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/request-discount
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases